<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36213211</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2387-0206</ISSN><JournalIssue CitedMedium="Internet"><Volume>159</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Medicina clinica (English ed.)</Title><ISOAbbreviation>Med Clin (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelae.</ArticleTitle><Pagination><StartPage>330</StartPage><EndPage>333</EndPage><MedlinePgn>330-333</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medcle.2022.02.027</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Follow-up after hospital discharge of SARS-CoV-2 survivors represents a huge burden on the healthcare system. We attempt to assess the utility of symptoms and health-related quality of life questionnaire (SF-12) to identify SARS CoV2 pulmonary sequelae.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Prospective, non-interventional follow-up study. A cardiopulmonary exercise test, functional respiratory test (PFT), SF12 questionnaire were performed after hospitalization at six months after the first positive PCR smear.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">41 patients were included, female (39%), mean age 57.3&#xa0;&#xb1;&#xa0;13.7 years. 70% persisted with symptoms. 46% presented a maximum oxygen consumption below 80% of predicted. SF-12 physical domain score was significantly reduced in patients with altered PFT (32.7 vs. 45.9; <i>p</i>&#xa0;&lt;&#xa0;0.001) and obtained the best sensitivity and specificity to identify PFT alterations (AUC 0.862, Sensitivity 85.7%, Specificity 81.5%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">SF-12 questionnaire shows high sensitivity and specificity to detect SARS CoV2 survivors with pulmonary function alterations.</AbstractText><CopyrightInformation>&#xa9; 2022 Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vannini</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Nuestra Se&#xf1;ora de Candelaria, Tenerife, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine and Public Health University Rey Juan Carlos, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laynez-Carnicero</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Nuestra Se&#xf1;ora de Candelaria, Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobis-Alvarez</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Nuestra Se&#xf1;ora de Candelaria, Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueroa-Mora</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Nuestra Se&#xf1;ora de Candelaria, Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poncela-Mireles</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Nuestra Se&#xf1;ora de Candelaria, Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Francisca Gonzalvo</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Department of Pneumology, Hospital Nuestra Se&#xf1;ora de Candelaria, Tenerife, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Clin (Engl Ed)</MedlineTA><NlmUniqueID>101711190</NlmUniqueID><ISSNLinking>2387-0206</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="ANTECEDENTES Y OBJETIVOS" NlmCategory="UNASSIGNED">El seguimiento tras el alta hospitalaria de los supervivientes de SARS-CoV-2 representa una enorme carga para el sistema sanitario. Intentamos evaluar la utilidad de los s&#xed;ntomas y el cuestionario de calidad de vida (SF-12) para identificar los pacientes con secuelas pulmonares por SARS-CoV-2.</AbstractText><AbstractText Label="MATERIALES Y M&#xc9;TODOS" NlmCategory="UNASSIGNED">Estudio de seguimiento prospectivo observacional. Despu&#xe9;s de la hospitalizaci&#xf3;n, a los 6 meses del primer frotis con PCR positiva se realizaron: una prueba de esfuerzo cardiopulmonar, pruebas funcionales respiratorias (PFR) y se aplic&#xf3; el cuestionario SF-12.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Se incluy&#xf3; a 41 pacientes, el 39% eran mujeres, con una edad media de 57,3&#xa0;&#xb1;&#xa0;13,7 a&#xf1;os. El 70% persist&#xed;a con s&#xed;ntomas. El 46% present&#xf3; un consumo m&#xe1;ximo de ox&#xed;geno por debajo del 80% del predicho. La puntuaci&#xf3;n del dominio f&#xed;sico del SF-12 fue significativamente m&#xe1;s baja en pacientes con PFR alteradas (32,7 vs. 45,9; <i>p</i>&#xa0;&lt;&#xa0;0,001) y obtuvo la mejor sensibilidad y especificidad para identificar las alteraciones de las PFR (AUC 0,862; sensibilidad 85,7% y especificidad 81,5%).</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">El cuestionario de calidad de vida SF-12 presenta una alta sensibilidad y especificidad para detectar a los sobrevivientes de SARS-CoV-2 con alteraciones de la funci&#xf3;n pulmonar.</AbstractText><CopyrightInformation>&#xa9; 2022 Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CPET</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Pulmonary function test</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">SF-12 quality of life questionnaire</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36213211</ArticleId><ArticleId IdType="pmc">PMC9526003</ArticleId><ArticleId IdType="doi">10.1016/j.medcle.2022.02.027</ArticleId><ArticleId IdType="pii">S2387-0206(22)00438-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-Month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Bobkova P., Spiridonova E., Shikhaleva A., Gamirova A., Blyuss O., et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021;51:1107&#x2013;1120. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilagut G., Mar&#xed;a Valderas J., Ferrer M., Garin O., L&#xf3;pez-Garc&#xed;a E., Alonsoab J. Interpretaci&#xf3;n de los cuestionarios de salud SF-36 y SF-12 en Espa&#xf1;a: componentes f&#xed;sico y mental. Med Clin (Barc) 2008;130:726&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pubmed">18570798</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J.E., Kosinski M., Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">8628042</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C., Caravita S., Faini A., Perego G.B., Senni M., Badano L.P., et al. Impact of COVID-19 on exercise pathophysiology. A combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021 doi: 10.1152/japplphysiol.00710.2020. japplphysiol.00710.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00710.2020</ArticleId><ArticleId IdType="pmc">PMC8143785</ArticleId><ArticleId IdType="pubmed">33764166</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P.M., Cullinan M., Lutchmansingh D.D., Gulati M., et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>